InspireMD (NSPR) Tops Q3 EPS by 2c

InspireMD (NYSE: NSPR) reported Q3 EPS of ($0.48), $0.02 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $632 thousand versus the consensus estimate of $900 thousand.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Centene names new CFO as Drew Asher plans to retire
• Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'